The UAE Ministry of Health has decided to recall all products that contain sibutramine substance according to the recommendations of the US Drug and Food Administration and European Association for Medicine and the request of the manufacturing company and agent in the UAE, WAM has reported. A Health Ministry official stated that sibutramine substance has been recalled from the markets immediately after the announcement of its clinical results that may cause heart attacks and cardiac arrests.
You might also like...
TotalEnergies to acquire remaining 50% SapuraOMV stake
26 April 2024
Hyundai E&C breaks ground on Jafurah gas project
26 April 2024
Abu Dhabi signs air taxi deals
26 April 2024
Spanish developer to invest in Saudi housing
26 April 2024
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.